Jiangsu Aidea Pharmaceutical (688488.SH) actual controller and president have collectively increased their holdings in the company by 762,700 shares.

Jiangsu Aidea Pharmaceutical (688488.SH) announced that from July 4, 2024 to December 27, 2024, Mr. Fu Heliang, one of the company's actual controllers and chairman, and Mr. Zhang Jie, the company's director and president, have acquired a total of 762,700 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding, accounting for 0.18% of the total share capital of the company. The total amount of the acquisition is 7.29 million yuan, which has exceeded the lower limit of the acquisition plan. The acquisition plan has been completed.